Oct 01, 2015

Bristol-Myers' gets early approval of combo cancer treatment

TRENTON, N.J. (AP) — The first combination of breakthrough drugs that boost the immune system to fight cancer has been approved, giving maker Bristol-Myers Squibb Co. an early lead over competitors testing other combos in a pharmaceutical gold rush of sorts. The Food and Drug Administration gave accelerated approval to a regimen combining the New York-based drugmaker's already-approved...

Proceed to the page: http://linkis.com/3RsSB

Similar Articles Added Earlier

Similar Articles Added Today

Latest Links Processed